NEAL HAHN: Open Payments
NPI 1043633506 · SAINT PAUL, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 10 payments from 8 companies in 2025. Trend: 2023 $415 · 2024 $360 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $52 |
| Astellas Pharma US Inc | 1 | $34 |
| PFIZER INC. | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: Ozempic, Veozah, PREVNAR 20, YUPELRI, DALVANCE, SPRAVATO, Rybelsus, INSPIRE.
Industry payments across NE — which companies pay providers there.
